Special offersSpecial offers
AntiviralsAntivirals
Famvir Generic Famvir
Famciclovir 250mg 		BUY NOWBUY NOW $3.00 Per pill
Lamprene Generic Lamprene
Clofazimine 50mg 		BUY NOWBUY NOW $2.75 Per pill
Rebetol Generic Rebetol
Ribavirin 200mg 		BUY NOWBUY NOW $7.50 Per pill
Relenza Generic Relenza
Zanamivir 5mg 		BUY NOWBUY NOW $149.98 Per item
Symmetrel Generic Symmetrel
Amantadine 100mg 		BUY NOWBUY NOW $1.11 Per pill
Tamiflu Generic Tamiflu
Oseltamivir 75mg 		BUY NOWBUY NOW $8.00 Per pill
Valtrex Generic Valtrex
Valacyclovir 0.5/1g 		BUY NOWBUY NOW $5.22 Per pill
Zovirax Generic Zovirax
Acyclovir 200/400/800mg 		BUY NOWBUY NOW $0.64 Per pill
Search for pillsSearch for pills

TestimonialsTestimonials
Dear Sir,

The order placed on the 19-05-2006 was delivered within 7 days, a most impressive service. Be assured that when I decide to place further orders I will contact you again, and will inform my friends of your excellent service.

Many thanks - Brian
Read more »Read more »
NewsNews
    Gilead tops table for antivirals - Pharma Times
    Gilead tops table for antiviralsPharma TimesWith combined sales from the top HIV treatment on the market, Atripla, and several other drugs, Gilead Sciences leads the antiviral market, closely followed by Bristol-Myers Squibb, Roche and Merck & Co
    Gilead shares slip on poor performance of hepatitis C drug - Bizjournals.com (blog)
    Gilead shares slip on poor performance of hepatitis C drugBizjournals
    Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide ... - MarketWatch (press release)
    CitybizlistIdenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide
    Gilead Drops After Patients Relapse on Hepatitis C Drug - BusinessWeek
    Proactive Investors USA & CanadaGilead Drops After Patients Relapse on Hepatitis C DrugBusinessWeekGilead will consider combining other direct-acting antivirals with 7977 and longer treatment times, company executives said on a conference call today with analysts and investors
    World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) - MarketWatch (press release)
    World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)MarketWatch (press release)NEW YORK, Feb
Live support Online Chat


Our billing is certified by
Secure shopping certificates






AR AU CA CZ DK EU FR GR IT NZ NO PL PT ES FI SE NL UK US HU TR